Self-monitoring of blood glucose did not improve glycaemic control in patients with type 2 diabetes not treated with insulin: Commentary by Farmer, A, Waldron-Lynch, F, Dinneen, S

In-depth immunophenotyping data of IL-6R on the human peripheral regulatory T cell (Treg) compartment by Ferreira, R, Rainbow, D, Garcia, A, Pekalski, M, Porter, L, Oliveira, J, Waldron-Lynch, F, Wicker, L, Todd, J

Human IL-6R(hi)TIGIT(-) CD4(+)CD127(low)CD25(+) T cells display potent in vitro suppressive capacity and a distinct Th17 profile by Ferreira, R, Rainbow, D, Rubio García, A, Pekalski, M, Porter, L, Oliveira, J, Waldron-Lynch, F, Wicker, L, Todd, J

In-depth immunophenotyping data of IL-6R on the human peripheral regulatory T cell (Treg) compartment. by Ferreira, R, Rainbow, D, Rubio García, A, Pekalski, M, Porter, L, Oliveira, J, Waldron-Lynch, F, Wicker, L, Todd, J

Human IL-6RhiTIGIT− CD4+CD127lowCD25+ T cells display potent in vitro suppressive capacity and a distinct Th17 profile by Ferreira, R, Rainbow, D, Rubio García, A, Pekalski, M, Porter, L, Oliveira, J, Waldron-Lynch, F, Wicker, L, Todd, J

Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes by Zhang, J-Y, Hamey, F, Trzupek, D, Mickunas, M, Lee, M, Godfrey, L, Yang, JHM, Pekalski, ML, Kennet, J, Waldron-Lynch, F, Evans, ML, Tree, TIM, Wicker, LS, Todd, JA, Ferreira, RC

Capturing the systemic immune signature of a norovirus infection: an n-of-1 case study within a clinical trial by Cutler, A, Oliveira, J, Ferreira, R, Challis, B, Walker, N, Caddy, S, Lu, J, Stevens, H, Smyth, D, Pekalski, M, Kennet, J, Hunter, K, Goodfellow, I, Wicker, L, Todd, J, Waldron-Lynch, F

The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes by Seelig, E, Howlett, J, Porter, L, Truman, L, Heywood, J, Kennet, J, Arbon, E, Anselmiova, K, Walker, N, Atkar, R, Pekalski, M, Rytina, E, Evans, M, Wicker, L, Todd, J, Mander, A, Bond, S, Waldron-Lynch, F

Neonatal and adult recent thymic emigrants produce IL-8 and express complement receptors CR1 and CR2 by Pekalski, M, García, A, Ferreira, R, Rainbow, D, Smyth, D, Mashar, M, Brady, J, Savinykh, N, Dopico, X, Mahmood, S, Duley, S, Stevens, H, Walker, N, Cutler, A, Waldron-Lynch, F, Dunger, D, Shannon-Lowe, C, Coles, A, Jones, J, Wallace, C, Todd, J, Wicker, L

Regulatory T cell responses in participants with type 1 diabetes after a single dose of interleukin-2: A non-randomised, open label, adaptive dose-finding trial by Todd, J, Evangelou, M, Cutler, A, Pekalski, M, Walker, N, Stevens, H, Porter, L, Smyth, D, Rainbow, D, Ferreira, R, Esposito, L, Hunter, K, Loudon, K, Irons, K, Yang, J, Bell, C, Schuilenburg, H, Heywood, J, Challis, B, Neupane, S, Clarke, P, Coleman, G, Dawson, S, Goymer, D, Anselmiova, K, Kennet, J, Brown, J, Caddy, S, Lu, J, Greatorex, J, Goodfellow, I, Wallace, C, Tree, T, Evans, M, Mander, A, Bond, S, Wicker, L, Waldron-Lynch, F